Aug 05, 2016 - Our proven model does not conclusively show that Jazz (JAZZ) is likely to beat earnings estimates this quarter.
May 25, 2016 - Stephon Alexander is a theoretical physicist, but he's also a jazz fanatic whose musical obsession has helped him better understand the world of cosmology, quantum gravity and particle physics.
Apr 01, 2016 - Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ) Investor Update Conference Call March 31, 2016 4:60 PM ET Executives Kathee Littrell – Vice President, Investor Relations Bruce Cozadd – Chairman and Chief Exe
Mar 28, 2016 - PDUFA date of March 31 means that an FDA decision is imminent.Defibrotide should obtain FDA approval in an orphan indication for which there is a substantial unmet need.Clinical trial results and prev
Sep 22, 2015 - Last year, there were 102 healthcare IPOs in the United States. 71 of these were biotech related, accounting for almost 25% of all IPOs in the U.S.Assuming sales growth forecasts of 15%, 7.6% and 9.1%
Sep 04, 2015 - Jazz Pharmaceuticals has an unfavorable Zacks Rank and the stock has been witnessing a significant price decline and negative earnings estimate revisions
Aug 25, 2015 - Alcobra, Jazz Pharmaceuticals, Nippon Telecom and Toyota Motor highlighted as Zacks Bull and Bear of the Day
Aug 25, 2015 - Bear of the Day: Jazz Pharma (JAZZ)
Aug 24, 2015 - The slump shouldn't be too much of a surprise to investors, as Jazz Pharmaceuticals has seen 1 negative revisions in the past few weeks and its current year earnings consensus has moved lower